Curevac Nv Stock Investor Sentiment
| CVAC Stock | USD 3.26 0.09 2.84% |
About 63% of all CureVac NV's shareholders are looking to take a long position. The analysis of the overall investor sentiment regarding CureVac NV suggests that some traders are interested. The current market sentiment, together with CureVac NV's historical and current headlines, can help investors time the market. In addition, many technical investors use CureVac NV stock news signals to limit their universe of possible portfolio assets.
CureVac NV Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards CureVac NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of CureVac NV's Stock prices. Below is the latest headlines and news related to CureVac NV Stock. The global stock market is bullish. About 65% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about CureVac NV that are available to investors today. This information is accessible both publicly - through CureVac NV's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of CureVac-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of CureVac NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CureVac NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CureVac NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CureVac NV alpha.
CureVac Largest EPS Surprises
Earnings surprises can significantly impact CureVac NV's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-12-31 | 2024-12-31 | -0.0908 | -0.14 | -0.0492 | 54 | ||
2022-08-18 | 2022-06-30 | -0.26 | -0.31 | -0.05 | 19 | ||
2023-08-17 | 2023-06-30 | -0.24 | -0.3 | -0.06 | 25 | ||
2023-05-30 | 2023-03-31 | -0.34 | -0.27 | 0.07 | 20 | ||
2024-08-15 | 2024-06-30 | -0.26 | -0.3482 | -0.0882 | 33 | ||
2020-11-30 | 2020-09-30 | -0.35 | -0.24 | 0.11 | 31 |
There is far too much social signal, news, headlines, and media speculation about CureVac NV that are available to investors today. This information is accessible both publicly - through CureVac NV's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of CureVac-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of CureVac NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of CureVac NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to CureVac NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive CureVac NV alpha.
CureVac NV Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Deadly Bird Flu Strain Detected In Nevada Man 4 Stocks To Watch | 02/10/2025 |
2 | CureVac Earns Repeat Recognition by LexisNexis as One of the Worlds Top Innovators | 02/18/2025 |
3 | FDA posts early alert after Calyxo urinary stone device tied to death | 03/21/2025 |
4 | CureVac Rises 10 percent After Key Patent Victory Other Movers in Focus | 03/28/2025 |
5 | CureVac Receives U.S. FDA IND Clearance to Initiate Phase 1 Clinical Trial for Novel mRNA-Based Precision Immunotherapy in Squamous Non-Small Cell Lung Cancer | 04/07/2025 |
6 | CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides ... | 04/10/2025 |
7 | Q4 2024 CureVac NV Earnings Call Transcript | 04/11/2025 |
8 | Calyxo Celebrates One Year Anniversary of the Launch of 2nd Generation CVAC System at American Urological Association 2025 Meeting | 04/23/2025 |
Complementary Tools for CureVac Stock analysis
When running CureVac NV's price analysis, check to measure CureVac NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CureVac NV is operating at the current time. Most of CureVac NV's value examination focuses on studying past and present price action to predict the probability of CureVac NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CureVac NV's price. Additionally, you may evaluate how the addition of CureVac NV to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance |